The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Pathogenesis and pathophysiology of bacterial meningitis
Open accessAbstract
Bacterial meningitis remains a disease with associated unacceptable morbidity and mortality rates despite the availability of effective bactericidal antimicrobial therapy. Through the use of experimental animal models of infection, a great deal of information has been gleaned concerning the pathogenic and pathophysiologic mechanisms operable in bacterial meningitis. Most cases of bacterial meningitis begin with host acquisition of a new organism by nasopharyngeal colonization followed by systemic invasion and development of a high-grade bacteremia. Bacterial encapsulation contributes to this bacteremia by inhibiting neutrophil phagocytosis and resisting classic complement-mediated bactericidal activity. Central nervous system invasion then occurs, although the exact site of bacterial traversal into the central nervous system is unknown. By production and/or release of virulence factors into and stimulation of formation of inflammatory cytokines within the central nervous system, meningeal pathogens increase permeability of the blood-brain barrier, thus allowing protein and neutrophils to move into the subarachnoid space. There is then an intense subarachnoid space inflammatory response, which leads to many of the pathophysiologic consequences of bacterial meningitis, including cerebral edema and increased intracranial pressure. Attenuation of this inflammatory response with adjunctive dexamethasone therapy is associated with reduced concentrations of tumor necrosis factor in the cerebrospinal fluid, with diminished cerebrospinal fluid leukocytosis, and perhaps with improvement of morbidity, as demonstrated in recent clinical trials. Further information on the pathogenesis and pathophysiology of bacterial meningitis should lead to the development of more innovative treatment and/or preventive strategies for this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., & Seed, B. (1989) · Science · doi:10.1126/science.2466335 · Cited by 2,005
Beachey, E. H. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.3.325 · Cited by 1,411
Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance
Beutler, B., Krochin, N., Milsark, I. W., Luedke, C., & Cerami, A. (1986) · Science · doi:10.1126/science.3754653 · Cited by 1,268
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S., & Gimbrone, M. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112200 · Cited by 1,104
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Fontana, A., Kristensen, F., Dubs, R., Gemsa, D., & Weber, E. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.6.2413 · Cited by 752
Nawroth, P. P., Bank, I., Handley, D., Cassimeris, J., Chess, L., & Stern, D. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1363 · Cited by 693
Ross, S. C., & Densen, P. (1984) · PubMed · Cited by 630
Dexamethasone Therapy for Bacterial Meningitis
Lebel, M. H., Freij, B. J., Syrogiannopoulos, G. A., Chrane, D. F., Hoyt, M. J., Stewart, S. M., Kennard, B. D., Olsen, K. D., & McCracken, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191502 · Cited by 606
Cited by
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
“…response may be effective in decreasing many of the pathophysiologic consequences of bacterial meningitis, such as cerebral edema, increased intracranial pressure, altered cerebral blood flow, cerebral vasculitis, and neuronal injury, as mediated by pro-inflammatory cytokine expression [45–47].”
Self-citationListeria Pathogenesis and Molecular Virulence Determinants
Vázquez-Boland, J. A., Kuhn, M., Berche, P., Chakraborty, T., Domı́nguez-Bernal, G., Goebel, W., González-Zorn, B., Wehland, J., & Kreft, J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.3.584-640.2001 · Cited by 2,152
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.144 · Cited by 588
The Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 429
Neisseria meningitidis: an overview of the carriage state
Yazdankhah, S. P., & Caugant, D. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45529-0 · Cited by 379
Does This Adult Patient Have Acute Meningitis?
Attia, J. (1999) · JAMA · doi:10.1001/jama.282.2.175 · Cited by 294
Yang, C.-T., Cambier, C. J., Davis, J. M., Hall, C. J., Crosier, P. S., & Ramakrishnan, L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.009 · Cited by 293
“Our findings place mycobacteria among the group of notorious pathogens that cause severe systemic disease, particularly meningitis, by evading neutrophil phagocytosis at least partially (Tunkel and Scheld, 1993).”
BackgroundMatrix Metalloproteinases Contribute to Brain Damage in Experimental Pneumococcal Meningitis
Leib, S. L., Leppert, D., Clements, J., & Täuber, M. G. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.615-620.2000 · Cited by 259
Sheu, J.-N., Liao, W.-C., Wu, U.-I., Shyu, L.-Y., Mai, F.-D., Chen, L.-Y., Chen, M.-J., Youn, S.-C., & Chang, H.-M. (2013) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2012.11.002 · Cited by 20
Metadata
- Authors
- Tunkel, A. R., & Scheld, W. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1993-04
- Volume
- 6
- Issue
- 2
- Pages
- 118-136
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1885560386
- Cited by
- 279
- References
- 125
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.